Application | Comment | Organism |
---|---|---|
medicine | the doxorubicin-inhibited NADH-quinone-reductase may provide a target for the anthracycline antitumor agents | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
doxorubicin | maximal inhibition at 0.001 mM | Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
plasma membrane | - |
Rattus norvegicus | 5886 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
57000 | - |
x * 57000, SDS-PAGE | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.186 | - |
NADH-ubiquinone-0 oxidoreductase activity | Rattus norvegicus |
10.3 | - |
NADH-ferricyanide oxidoreductase activity | Rattus norvegicus |
10.3 | - |
reduction of K3Fe(CN)6 | Rattus norvegicus |
13.2 | - |
reduction of Coenzyme Q10 | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
NADH + coenzyme Q10 | - |
Rattus norvegicus | ? | - |
? | |
NADH + Fe(CN)63- | - |
Rattus norvegicus | ? | - |
? | |
NADH + ubiquinone | - |
Rattus norvegicus | NAD+ + ubiquinol | - |
? | |
NADH + ubiquinone-0 | - |
Rattus norvegicus | NAD+ + ubiquinol-0 | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 57000, SDS-PAGE | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
NADH-quinone (NADH-ferricyanide) reductase | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Rattus norvegicus |